COMPARATIVE THERMODYNAMIC STUDY OF THE INTERACTION OF SOME ANTIFOLATES WITH DIHYDROFOLATE-REDUCTASE

被引:10
作者
GILLI, RM [1 ]
SARI, JC [1 ]
LOPEZ, CL [1 ]
RIMET, OS [1 ]
BRIAND, CM [1 ]
机构
[1] FAC PHARM MARSEILLE, PHYS PHARMACEUT LAB, 27 BLVD JEAN MOULIN, F-13385 MARSEILLE 5, FRANCE
关键词
Antifolate binding; Dihydrofolate reductase; NADPH; Trimethoprim; Trimetrexate;
D O I
10.1016/0167-4838(90)90083-R
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The thermodynamic parameters of the binding of antifolate drugs to bovine liver dihydrofolate reductase (EC 1.5.1.3., 5,6,7,8-tetrahydrofolate: NADP+ oxidoreductase) have been measured with a flow microcalorimetric method. These parameters are greatly influenced by the structure of the inhibitor and/or by the presence of NADPH and above all by temperature. For all the compounds studied, binding at 37°C is driven by favourable enthalpy variations, whereas entropy variations are unfavourable. At 10°C, reactions are both enthalpically and entropically driven. These effects can be explained by a partial thermal denaturation of dihydrofolate reductase at 37°C, which is restructured by NADPH and/or the antifolate. The refolding induced by the antifolate trimetrexate may explain its high association constant in the binary system (without NADPH), and the weaker cooperative effect of NADPH in the ternary system, as compared to methotrexate. In contrast, the poor affinity of trimethoprim for mammalian dihydrofolate reduçtase in binary and ternary systems at 37°C is the result of a weaker stabilizing effect of this compound as regards temperature increase. Heat capacity variation linked to the complex formation reaction showed that this conformational transition is more pronounced between 25 and 37°C than between 10 and 25°C. Thus, the ability of the inhibitors to give to dihydrofolate reductase a more stable thermal behaviour at 37°C is determinant in their binding. © 1990.
引用
收藏
页码:245 / 250
页数:6
相关论文
共 24 条
[1]   INHIBITION OF DIHYDROFOLATE-REDUCTASE - EFFECT OF REDUCED NICOTINAMIDE ADENINE-DINUCLEOTIDE PHOSPHATE ON THE SELECTIVITY AND AFFINITY OF DIAMINOBENZYLPYRIMIDINES [J].
BACCANARI, DP ;
DALUGE, S ;
KING, RW .
BIOCHEMISTRY, 1982, 21 (20) :5068-5075
[2]   2,4-DIAMINO-5-METHYL-6-[(3,4,5-TRIMETHOXYANILINO)METHYL]QUINAZOLINE (TMQ), A POTENT NON-CLASSICAL FOLATE ANTAGONIST INHIBITOR .1. EFFECT ON DIHYDROFOLATE-REDUCTASE AND GROWTH OF RODENT TUMORS INVITRO AND INVIVO [J].
BERTINO, JR ;
SAWICKI, WL ;
MOROSON, BA ;
CASHMORE, AR ;
ELSLAGER, EF .
BIOCHEMICAL PHARMACOLOGY, 1979, 28 (12) :1983-1987
[3]   DIHYDROFOLATE-REDUCTASE - MULTIPLE CONFORMATIONS AND ALTERNATIVE MODES OF SUBSTRATE BINDING [J].
BIRDSALL, B ;
FEENEY, J ;
TENDLER, SJB ;
HAMMOND, SJ ;
ROBERTS, GCK .
BIOCHEMISTRY, 1989, 28 (05) :2297-2305
[4]   NMR-STUDIES OF DIFFERENCES IN THE CONFORMATIONS AND DYNAMICS OF LIGAND COMPLEXES FORMED WITH MUTANT DIHYDROFOLATE REDUCTASES [J].
BIRDSALL, B ;
ANDREWS, J ;
OSTLER, G ;
TENDLER, SJB ;
FEENEY, J ;
ROBERTS, GCK ;
DAVIES, RW ;
CHEUNG, HTA .
BIOCHEMISTRY, 1989, 28 (03) :1353-1362
[5]  
BOLIN JT, 1982, J BIOL CHEM, V257, P13650
[6]   PROTONATED STATE OF METHOTREXATE, TRIMETHOPRIM, AND PYRIMETHAMINE BOUND TO DIHYDROFOLATE-REDUCTASE [J].
COCCO, L ;
ROTH, B ;
TEMPLE, C ;
MONTGOMERY, JA ;
LONDON, RE ;
BLAKLEY, RL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1983, 226 (02) :567-577
[7]   THE THYMIDYLATE SYNTHESIS CYCLE AND ANTICANCER DRUGS [J].
DOUGLAS, KT .
MEDICINAL RESEARCH REVIEWS, 1987, 7 (04) :441-475
[8]  
FREISHEIM JH, 1984, FOLATE ANTAGONISTS T, V1, P69
[9]  
GALIVAN J, 1989, J BIOL CHEM, V264, P10685
[10]   MICROCALORIMETRIC STUDY OF A COMPETITIVE EFFECT BETWEEN SOME INHIBITORS WITH A MAMMALIAN DIHYDROFOLATE-REDUCTASE [J].
GILLI, R ;
SARI, JC ;
CHAUVET, M ;
BOURDEAUX, M ;
BRIAND, C .
THERMOCHIMICA ACTA, 1985, 85 (APR) :505-508